{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:30Z","timestamp":1786985070036,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.bcmd.2006.10.008","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T07:24:59Z","timestamp":1165994699000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents"],"prefix":"10.1016","volume":"38","author":[{"given":"Sajal K.","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora W.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idowu","family":"Akinsheye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Perrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas V.","family":"Faller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2006.10.008_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7326\/0003-4819-118-1-199301010-00009","article-title":"NIH conference. Epstein\u2013Barr virus infections: biology, pathogenesis, and management","volume":"118","author":"Straus","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2006.10.008_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt's lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2006.10.008_bib3","first-page":"376","article-title":"Nasopharyngeal carcinoma: the Epstein\u2013Barr virus association","volume":"21","author":"Liebowitz","year":"1994","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.177.2.339","article-title":"Epstein\u2013Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells","volume":"177","author":"Deacon","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2006.10.008_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2559.1994.tb01350.x","article-title":"Monoclonal Epstein\u2013Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma","volume":"25","author":"Ott","year":"1994","journal-title":"Histopathology"},{"key":"10.1016\/j.bcmd.2006.10.008_bib6","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199411000-00010","article-title":"In situ detection of Epstein\u2013Barr virus in gastric and colorectal adenocarcinomas","volume":"18","author":"Yuen","year":"1994","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib7","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/jnci\/91.16.1376","article-title":"Detection of Epstein\u2013Barr virus in invasive breast cancers","volume":"91","author":"Bonnet","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bcmd.2006.10.008_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jnci\/92.8.655","article-title":"Re: detection of Epstein\u2013Barr virus in invasive breast cancers","volume":"92","author":"Brink","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bcmd.2006.10.008_bib9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199509143331103","article-title":"Clonal proliferations of cells infected with Epstein\u2013Barr virus in preinvasive lesions related to nasopharyngeal carcinoma","volume":"333","author":"Pathmanathan","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2006.10.008_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","article-title":"Detection of Epstein\u2013Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease","volume":"320","author":"Weiss","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2006.10.008_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.19.1.657","article-title":"X-linked lymphoproliferative disease: a progressive immunodeficiency","volume":"19","author":"Morra","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib12","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood.V81.8.2102.2102","article-title":"Epstein\u2013Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus","volume":"81","author":"Shibata","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2006.10.008_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jcp.53.4.248","article-title":"The role of EBV in post-transplant malignancies: a review","volume":"53","author":"Hopwood","year":"2000","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib14","series-title":"Fundamental Virology","first-page":"1109","article-title":"Epstein\u2013Barr virus and its replication","author":"Kieff","year":"1996"},{"key":"10.1016\/j.bcmd.2006.10.008_bib15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1056\/NEJM199609053351007","article-title":"Ganciclovir","volume":"335","author":"Crumpacker","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2006.10.008_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jama.1988.03720030044031","article-title":"Regression of oral hairy leukoplakia after orally administered acyclovir therapy","volume":"259","author":"Resnick","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.bcmd.2006.10.008_bib17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00001622-200109000-00008","article-title":"Induction of the Epstein\u2013Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein\u2013Barr virus-associated malignancies","volume":"13","author":"Faller","year":"2001","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib18","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1038\/sj.onc.1206548","article-title":"Virally targeted therapies for EBV-associated malignancies","volume":"22","author":"Israel","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2006.10.008_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/bcmd.1998.0178","article-title":"Arginine butyrate-induced susceptibility to ganciclovir in an Epstein\u2013Barr-virus-associated lymphoma","volume":"24","author":"Mentzer","year":"1998","journal-title":"Blood Cells, Mol. Dis."},{"key":"10.1016\/j.bcmd.2006.10.008_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1034\/j.1399-3062.2001.003003177.x","article-title":"Epstein\u2013Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate","volume":"3","author":"Mentzer","year":"2001","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.bcmd.2006.10.008_bib21","first-page":"965","article-title":"Experimental treatment of Epstein\u2013Barr virus-associated primary central nervous system lymphoma","volume":"63","author":"Roychowdhury","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2006.10.008_bib22","first-page":"5781","article-title":"Activation of lytic Epstein\u2013Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies","volume":"60","author":"Westphal","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2006.10.008_bib23","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1128\/JVI.79.9.5875-5879.2005","article-title":"Induction of lytic Epstein\u2013Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo","volume":"79","author":"Daibata","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib24","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for Epstein\u2013Barr virus-positive B-cell lymphomas","volume":"78","author":"Feng","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib25","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1128\/AAC.45.7.2082-2091.2001","article-title":"Induction of Epstein\u2013Barr virus kinases to sensitize tumor cells to nucleoside analogues","volume":"45","author":"Moore","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcmd.2006.10.008_bib26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0277-5379(87)90109-X","article-title":"Clinical pharmacology of sodium butyrate in patients with acute leukemia","volume":"23","author":"Miller","year":"1987","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1097-0142(19830101)51:1<9::AID-CNCR2820510104>3.0.CO;2-4","article-title":"Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child","volume":"51","author":"Novogrodsky","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2006.10.008_bib28","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcmd.2006.10.008_bib29","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1182\/blood-2002-02-0353","article-title":"Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo","volume":"100","author":"Pace","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2006.10.008_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01309995","article-title":"Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein\u2013Barr virus antigens and cell differentiation","volume":"81","author":"Anisimova","year":"1984","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib31","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1128\/jvi.64.11.5441-5447.1990","article-title":"Up regulation of the Epstein\u2013Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection","volume":"64","author":"Contreras-Salazar","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0042-6822(80)90326-8","article-title":"Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein\u2013Barr virus","volume":"107","author":"Saemundsen","year":"1980","journal-title":"Virology"},{"key":"10.1016\/j.bcmd.2006.10.008_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0092-8674(78)90306-9","article-title":"The effect of sodium butyrate on histone modification","volume":"14","author":"Sealy","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2006.10.008_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/viro.2002.1638","article-title":"Epstein\u2013Barr virus latent membrane protein-1 induction by histone deacetylase inhibitors mediates induction of intercellular adhesion molecule-1 expression and homotypic aggregation","volume":"303","author":"Park","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.bcmd.2006.10.008_bib35","article-title":"A phase I\/II study of arginine butyrate and ganciclovir in patients with Epstein\u2013Barr virus-associated lymphoid malignancies","author":"Perrine","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2006.10.008_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s002800050922","article-title":"Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats","volume":"43","author":"Egorin","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein\u2013Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2006.10.008_bib38","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1128\/jvi.61.12.3672-3679.1987","article-title":"Polymorphic proteins encoded within BZLF1 of defective and standard Epstein\u2013Barr viruses disrupt latency","volume":"61","author":"Countryman","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib39","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1002\/j.1460-2075.1986.tb04635.x","article-title":"Both Epstein\u2013Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter","volume":"5","author":"Chevallier-Greco","year":"1986","journal-title":"EMBO J."},{"key":"10.1016\/j.bcmd.2006.10.008_bib40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.74.2.710-720.2000","article-title":"Histone acetylation and reactivation of Epstein\u2013Barr virus from latency","volume":"74","author":"Jenkins","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib41","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s007050050636","article-title":"Demethylation of the Epstein\u2013Barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report","volume":"144","author":"Falk","year":"1999","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bcmd.2006.10.008_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/embo-reports\/kvf031","article-title":"MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling","volume":"3","author":"Gruffat","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcmd.2006.10.008_bib43","first-page":"465","article-title":"Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals","volume":"9","author":"Vaziri","year":"1998","journal-title":"Cell Growth Differ."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979606002336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979606002336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:23:18Z","timestamp":1761049398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979606002336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1079979606002336"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2006.10.008","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2006.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}